drugset / Trial / NCT05831007
Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)
Unknown
6 enrolled
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Innostellar Biotherapeutics · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to evaluate the safety and efficacy of LX102-C01 treatment of nAMD. This study will enroll subjects aged ≥ 50 years old to receive a single unilateral intravitreal (IVT) injection of LX102-C01 to evaluate its safety and efficacy.
Timeline
- Start
- 2021-12-06
- Primary completion
- 2023-06
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX102-C01 | Unknown | 3e+10 vg | Intravitreal |
| Subject | LX102-C01 | Unknown | 1e+11 vg | Intravitreal |